Uridine-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data
Report Summary
Uridine-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on Uridine industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Uridine 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Uridine worldwide and market share by regions, with company and product introduction, position in the Uridine market
Market status and development trend of Uridine by types and applications
Cost and profit status of Uridine, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Uridine market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Uridine industry.
The report segments the global Uridine market as:
Global Uridine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Uridine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
PurityMoreThan99%
PurityMoreThan98%
Others
Global Uridine Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
FluorouracilDeoxynucleoside
Iodoside
Others
Global Uridine Market: Manufacturers Segment Analysis (Company and Product introduction, Uridine Sales Volume, Revenue, Price and Gross Margin):
BioSpectra
VenkatasaiLifeSciences
TuoxinPharmaceutical
MeiyaPharmaceutical
FengchenGroup
AosenNewMaterialTechnologyCo
BiocompoundsPharmaceutical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Uridine-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on Uridine industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Uridine 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Uridine worldwide and market share by regions, with company and product introduction, position in the Uridine market
Market status and development trend of Uridine by types and applications
Cost and profit status of Uridine, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Uridine market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Uridine industry.
The report segments the global Uridine market as:
Global Uridine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Uridine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
PurityMoreThan99%
PurityMoreThan98%
Others
Global Uridine Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
FluorouracilDeoxynucleoside
Iodoside
Others
Global Uridine Market: Manufacturers Segment Analysis (Company and Product introduction, Uridine Sales Volume, Revenue, Price and Gross Margin):
BioSpectra
VenkatasaiLifeSciences
TuoxinPharmaceutical
MeiyaPharmaceutical
FengchenGroup
AosenNewMaterialTechnologyCo
BiocompoundsPharmaceutical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF URIDINE
1.1 Definition of Uridine in This Report
1.2 Commercial Types of Uridine
1.2.1 PurityMoreThan99%
1.2.2 PurityMoreThan98%
1.2.3 Others
1.3 Downstream Application of Uridine
1.3.1 FluorouracilDeoxynucleoside
1.3.2 Iodoside
1.3.3 Others
1.4 Development History of Uridine
1.5 Market Status and Trend of Uridine 2016-2026
1.5.1 Global Uridine Market Status and Trend 2016-2026
1.5.2 Regional Uridine Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Uridine 2016-2021
2.2 Sales Market of Uridine by Regions
2.2.1 Sales Volume of Uridine by Regions
2.2.2 Sales Value of Uridine by Regions
2.3 Production Market of Uridine by Regions
2.4 Global Market Forecast of Uridine 2022-2026
2.4.1 Global Market Forecast of Uridine 2022-2026
2.4.2 Market Forecast of Uridine by Regions 2022-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Uridine by Types
3.2 Sales Value of Uridine by Types
3.3 Market Forecast of Uridine by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Uridine by Downstream Industry
4.2 Global Market Forecast of Uridine by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Uridine Market Status by Countries
5.1.1 North America Uridine Sales by Countries (2016-2021)
5.1.2 North America Uridine Revenue by Countries (2016-2021)
5.1.3 United States Uridine Market Status (2016-2021)
5.1.4 Canada Uridine Market Status (2016-2021)
5.1.5 Mexico Uridine Market Status (2016-2021)
5.2 North America Uridine Market Status by Manufacturers
5.3 North America Uridine Market Status by Type (2016-2021)
5.3.1 North America Uridine Sales by Type (2016-2021)
5.3.2 North America Uridine Revenue by Type (2016-2021)
5.4 North America Uridine Market Status by Downstream Industry (2016-2021)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Uridine Market Status by Countries
6.1.1 Europe Uridine Sales by Countries (2016-2021)
6.1.2 Europe Uridine Revenue by Countries (2016-2021)
6.1.3 Germany Uridine Market Status (2016-2021)
6.1.4 UK Uridine Market Status (2016-2021)
6.1.5 France Uridine Market Status (2016-2021)
6.1.6 Italy Uridine Market Status (2016-2021)
6.1.7 Russia Uridine Market Status (2016-2021)
6.1.8 Spain Uridine Market Status (2016-2021)
6.1.9 Benelux Uridine Market Status (2016-2021)
6.2 Europe Uridine Market Status by Manufacturers
6.3 Europe Uridine Market Status by Type (2016-2021)
6.3.1 Europe Uridine Sales by Type (2016-2021)
6.3.2 Europe Uridine Revenue by Type (2016-2021)
6.4 Europe Uridine Market Status by Downstream Industry (2016-2021)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Uridine Market Status by Countries
7.1.1 Asia Pacific Uridine Sales by Countries (2016-2021)
7.1.2 Asia Pacific Uridine Revenue by Countries (2016-2021)
7.1.3 China Uridine Market Status (2016-2021)
7.1.4 Japan Uridine Market Status (2016-2021)
7.1.5 India Uridine Market Status (2016-2021)
7.1.6 Southeast Asia Uridine Market Status (2016-2021)
7.1.7 Australia Uridine Market Status (2016-2021)
7.2 Asia Pacific Uridine Market Status by Manufacturers
7.3 Asia Pacific Uridine Market Status by Type (2016-2021)
7.3.1 Asia Pacific Uridine Sales by Type (2016-2021)
7.3.2 Asia Pacific Uridine Revenue by Type (2016-2021)
7.4 Asia Pacific Uridine Market Status by Downstream Industry (2016-2021)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Uridine Market Status by Countries
8.1.1 Latin America Uridine Sales by Countries (2016-2021)
8.1.2 Latin America Uridine Revenue by Countries (2016-2021)
8.1.3 Brazil Uridine Market Status (2016-2021)
8.1.4 Argentina Uridine Market Status (2016-2021)
8.1.5 Colombia Uridine Market Status (2016-2021)
8.2 Latin America Uridine Market Status by Manufacturers
8.3 Latin America Uridine Market Status by Type (2016-2021)
8.3.1 Latin America Uridine Sales by Type (2016-2021)
8.3.2 Latin America Uridine Revenue by Type (2016-2021)
8.4 Latin America Uridine Market Status by Downstream Industry (2016-2021)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Uridine Market Status by Countries
9.1.1 Middle East and Africa Uridine Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Uridine Revenue by Countries (2016-2021)
9.1.3 Middle East Uridine Market Status (2016-2021)
9.1.4 Africa Uridine Market Status (2016-2021)
9.2 Middle East and Africa Uridine Market Status by Manufacturers
9.3 Middle East and Africa Uridine Market Status by Type (2016-2021)
9.3.1 Middle East and Africa Uridine Sales by Type (2016-2021)
9.3.2 Middle East and Africa Uridine Revenue by Type (2016-2021)
9.4 Middle East and Africa Uridine Market Status by Downstream Industry (2016-2021)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF URIDINE
10.1 Global Economy Situation and Trend Overview
10.2 Uridine Downstream Industry Situation and Trend Overview
CHAPTER 11 URIDINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Uridine by Major Manufacturers
11.2 Production Value of Uridine by Major Manufacturers
11.3 Basic Information of Uridine by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Uridine Major Manufacturer
11.3.2 Employees and Revenue Level of Uridine Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 URIDINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 BioSpectra
12.1.1 Company profile
12.1.2 Representative Uridine Product
12.1.3 Uridine Sales, Revenue, Price and Gross Margin of BioSpectra
12.2 VenkatasaiLifeSciences
12.2.1 Company profile
12.2.2 Representative Uridine Product
12.2.3 Uridine Sales, Revenue, Price and Gross Margin of VenkatasaiLifeSciences
12.3 TuoxinPharmaceutical
12.3.1 Company profile
12.3.2 Representative Uridine Product
12.3.3 Uridine Sales, Revenue, Price and Gross Margin of TuoxinPharmaceutical
12.4 MeiyaPharmaceutical
12.4.1 Company profile
12.4.2 Representative Uridine Product
12.4.3 Uridine Sales, Revenue, Price and Gross Margin of MeiyaPharmaceutical
12.5 FengchenGroup
12.5.1 Company profile
12.5.2 Representative Uridine Product
12.5.3 Uridine Sales, Revenue, Price and Gross Margin of FengchenGroup
12.6 AosenNewMaterialTechnologyCo
12.6.1 Company profile
12.6.2 Representative Uridine Product
12.6.3 Uridine Sales, Revenue, Price and Gross Margin of AosenNewMaterialTechnologyCo
12.7 BiocompoundsPharmaceutical
12.7.1 Company profile
12.7.2 Representative Uridine Product
12.7.3 Uridine Sales, Revenue, Price and Gross Margin of BiocompoundsPharmaceutical
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF URIDINE
13.1 Industry Chain of Uridine
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF URIDINE
14.1 Cost Structure Analysis of Uridine
14.2 Raw Materials Cost Analysis of Uridine
14.3 Labor Cost Analysis of Uridine
14.4 Manufacturing Expenses Analysis of Uridine
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Uridine in This Report
1.2 Commercial Types of Uridine
1.2.1 PurityMoreThan99%
1.2.2 PurityMoreThan98%
1.2.3 Others
1.3 Downstream Application of Uridine
1.3.1 FluorouracilDeoxynucleoside
1.3.2 Iodoside
1.3.3 Others
1.4 Development History of Uridine
1.5 Market Status and Trend of Uridine 2016-2026
1.5.1 Global Uridine Market Status and Trend 2016-2026
1.5.2 Regional Uridine Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Uridine 2016-2021
2.2 Sales Market of Uridine by Regions
2.2.1 Sales Volume of Uridine by Regions
2.2.2 Sales Value of Uridine by Regions
2.3 Production Market of Uridine by Regions
2.4 Global Market Forecast of Uridine 2022-2026
2.4.1 Global Market Forecast of Uridine 2022-2026
2.4.2 Market Forecast of Uridine by Regions 2022-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Uridine by Types
3.2 Sales Value of Uridine by Types
3.3 Market Forecast of Uridine by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Uridine by Downstream Industry
4.2 Global Market Forecast of Uridine by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Uridine Market Status by Countries
5.1.1 North America Uridine Sales by Countries (2016-2021)
5.1.2 North America Uridine Revenue by Countries (2016-2021)
5.1.3 United States Uridine Market Status (2016-2021)
5.1.4 Canada Uridine Market Status (2016-2021)
5.1.5 Mexico Uridine Market Status (2016-2021)
5.2 North America Uridine Market Status by Manufacturers
5.3 North America Uridine Market Status by Type (2016-2021)
5.3.1 North America Uridine Sales by Type (2016-2021)
5.3.2 North America Uridine Revenue by Type (2016-2021)
5.4 North America Uridine Market Status by Downstream Industry (2016-2021)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Uridine Market Status by Countries
6.1.1 Europe Uridine Sales by Countries (2016-2021)
6.1.2 Europe Uridine Revenue by Countries (2016-2021)
6.1.3 Germany Uridine Market Status (2016-2021)
6.1.4 UK Uridine Market Status (2016-2021)
6.1.5 France Uridine Market Status (2016-2021)
6.1.6 Italy Uridine Market Status (2016-2021)
6.1.7 Russia Uridine Market Status (2016-2021)
6.1.8 Spain Uridine Market Status (2016-2021)
6.1.9 Benelux Uridine Market Status (2016-2021)
6.2 Europe Uridine Market Status by Manufacturers
6.3 Europe Uridine Market Status by Type (2016-2021)
6.3.1 Europe Uridine Sales by Type (2016-2021)
6.3.2 Europe Uridine Revenue by Type (2016-2021)
6.4 Europe Uridine Market Status by Downstream Industry (2016-2021)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Uridine Market Status by Countries
7.1.1 Asia Pacific Uridine Sales by Countries (2016-2021)
7.1.2 Asia Pacific Uridine Revenue by Countries (2016-2021)
7.1.3 China Uridine Market Status (2016-2021)
7.1.4 Japan Uridine Market Status (2016-2021)
7.1.5 India Uridine Market Status (2016-2021)
7.1.6 Southeast Asia Uridine Market Status (2016-2021)
7.1.7 Australia Uridine Market Status (2016-2021)
7.2 Asia Pacific Uridine Market Status by Manufacturers
7.3 Asia Pacific Uridine Market Status by Type (2016-2021)
7.3.1 Asia Pacific Uridine Sales by Type (2016-2021)
7.3.2 Asia Pacific Uridine Revenue by Type (2016-2021)
7.4 Asia Pacific Uridine Market Status by Downstream Industry (2016-2021)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Uridine Market Status by Countries
8.1.1 Latin America Uridine Sales by Countries (2016-2021)
8.1.2 Latin America Uridine Revenue by Countries (2016-2021)
8.1.3 Brazil Uridine Market Status (2016-2021)
8.1.4 Argentina Uridine Market Status (2016-2021)
8.1.5 Colombia Uridine Market Status (2016-2021)
8.2 Latin America Uridine Market Status by Manufacturers
8.3 Latin America Uridine Market Status by Type (2016-2021)
8.3.1 Latin America Uridine Sales by Type (2016-2021)
8.3.2 Latin America Uridine Revenue by Type (2016-2021)
8.4 Latin America Uridine Market Status by Downstream Industry (2016-2021)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Uridine Market Status by Countries
9.1.1 Middle East and Africa Uridine Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Uridine Revenue by Countries (2016-2021)
9.1.3 Middle East Uridine Market Status (2016-2021)
9.1.4 Africa Uridine Market Status (2016-2021)
9.2 Middle East and Africa Uridine Market Status by Manufacturers
9.3 Middle East and Africa Uridine Market Status by Type (2016-2021)
9.3.1 Middle East and Africa Uridine Sales by Type (2016-2021)
9.3.2 Middle East and Africa Uridine Revenue by Type (2016-2021)
9.4 Middle East and Africa Uridine Market Status by Downstream Industry (2016-2021)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF URIDINE
10.1 Global Economy Situation and Trend Overview
10.2 Uridine Downstream Industry Situation and Trend Overview
CHAPTER 11 URIDINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Uridine by Major Manufacturers
11.2 Production Value of Uridine by Major Manufacturers
11.3 Basic Information of Uridine by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Uridine Major Manufacturer
11.3.2 Employees and Revenue Level of Uridine Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 URIDINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 BioSpectra
12.1.1 Company profile
12.1.2 Representative Uridine Product
12.1.3 Uridine Sales, Revenue, Price and Gross Margin of BioSpectra
12.2 VenkatasaiLifeSciences
12.2.1 Company profile
12.2.2 Representative Uridine Product
12.2.3 Uridine Sales, Revenue, Price and Gross Margin of VenkatasaiLifeSciences
12.3 TuoxinPharmaceutical
12.3.1 Company profile
12.3.2 Representative Uridine Product
12.3.3 Uridine Sales, Revenue, Price and Gross Margin of TuoxinPharmaceutical
12.4 MeiyaPharmaceutical
12.4.1 Company profile
12.4.2 Representative Uridine Product
12.4.3 Uridine Sales, Revenue, Price and Gross Margin of MeiyaPharmaceutical
12.5 FengchenGroup
12.5.1 Company profile
12.5.2 Representative Uridine Product
12.5.3 Uridine Sales, Revenue, Price and Gross Margin of FengchenGroup
12.6 AosenNewMaterialTechnologyCo
12.6.1 Company profile
12.6.2 Representative Uridine Product
12.6.3 Uridine Sales, Revenue, Price and Gross Margin of AosenNewMaterialTechnologyCo
12.7 BiocompoundsPharmaceutical
12.7.1 Company profile
12.7.2 Representative Uridine Product
12.7.3 Uridine Sales, Revenue, Price and Gross Margin of BiocompoundsPharmaceutical
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF URIDINE
13.1 Industry Chain of Uridine
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF URIDINE
14.1 Cost Structure Analysis of Uridine
14.2 Raw Materials Cost Analysis of Uridine
14.3 Labor Cost Analysis of Uridine
14.4 Manufacturing Expenses Analysis of Uridine
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
